Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Original Research
Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,671 | Dovepress* | 4,210+ | 145 | 4,355 | |
| PubMed Central* | 461 | 203 | 664 | ||
| Totals | 4,671 | 348 | 5,019 | ||
| *Since 1 October 2022 | |||||
View citations on PubMed Central and Google Scholar